Divi’s Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25%
Divi’s Laboratories, a leading Indian manufacturer of active pharmaceutical ingredients (APIs), delivered an impressive financial performance in the third quarter (Q3) of FY 2024-25, with a 64.52% increase in consolidated net profit. The company’s net profit surged to ₹589 crore, compared to ₹358 crore in the same quarter last year, according to its latest exchange…